Less Ads, More Data, More Tools Register for FREE

Pin to quick picksAstrazeneca Share News (AZN)

Share Price Information for Astrazeneca (AZN)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 12,190.00
Bid: 12,210.00
Ask: 12,214.00
Change: 162.00 (1.35%)
Spread: 4.00 (0.033%)
Open: 12,036.00
High: 12,214.00
Low: 12,024.00
Prev. Close: 12,028.00
AZN Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

LONDON MARKET MIDDAY: Brexit Deal Euphoria Sends FTSE To 9-Month High

Tue, 29th Dec 2020 12:24

(Alliance News) - Stocks in London were powering higher at midday on Tuesday following the Christmas break, with the FTSE 100 at a level last seen before the nationwide lockdown in March, as investors cheered a long-awaited, last-minute post-Brexit trade deal.

The FTSE 100 index was up 140.94 points, or 2.2%, at 6,643.05. The large cap index hit an intraday high of 6,676.60 in early trade - its highest reading since March.

The mid-cap FTSE 250 index was up 474.66 points, or 2.3%, at 21,021.31. The AIM All-Share index was up 1.8% at 1,147.86.

The Cboe UK 100 index was up 2.2% at 661.11. The Cboe 250 was up 2.3% at 18,353.40, and the Cboe Small Companies up 0.8% at 11,673.85.

In mainland Europe, the CAC 40 in Paris was up 0.3%, while the DAX 30 in Frankfurt was up 0.4%.

Last Thursday the UK reached an agreement with the European Union which allows for continued tariff-free trade with the EU single market.

"The FTSE 100 and FTSE 250 are both up nicely in the early exchanges and sterling is holding on to the USD1.35 and EUR1.10 marks, so markets seem to be welcoming the Brexit deal that was announced on Christmas Eve," said AJ Bell Investment Director Russ Mould. "However, the agreement struck between London and Brussels is yet to win universal acclaim, even if that is the inevitable result of the compromises that the prime minister had to make to get the deal over the line before the end of the transition period and confirmation of the UK's departure from the economic bloc."

EU ambassadors have given provisional approval for Britain's post-Brexit trade deal, which will be implemented from Friday.

A spokesman for the German EU presidency said the ambassadors had unanimously agreed to "green light" the settlement hammered out on Christmas Eve. It comes as UK MPs were preparing to vote on the deal in a special sitting of Parliament called for Wednesday.

The agreement came as ministers stepped up calls for businesses and individuals to prepare for the new procedures that will apply in just four days' time, regardless of the agreement.

In the FTSE 100, AstraZeneca was up 4.0%, amid hopes the Anglo-Swedish drugmaker's coronavirus vaccine, created in partnership with Oxford University, will be rolled out imminently.

Over the weekend, the Sunday Telegraph reported the Oxford jab could be rolled out en masse from a few days into the New Year.

According to the newspaper, the UK government hopes that the approval could mean more than two million could receive their first dose within a fortnight, with doses of the Oxford vaccine available from next Monday.

Further, AstraZeneca on Monday said its Lynparza cancer treatment has secured approval in Japan for the treatment of advanced ovarian, prostate and pancreatic cancers.

Admiral Group was up 3.5%. The insurer said it has reached an agreement with ZPG Comparison Services Holdings UK's RVU business over the sale of the insurer's Penguin Portals and Preminen comparison businesses, for a total value of GBP508 million.

Penguin Portals is made up of online comparison portals Confused.com, Rastreator.com and LeLynx.fr, technology operations Admiral Technologies and its 50% share of Preminen Price Comparison Holdings.

Cardiff-based Admiral expects net proceeds of around GBP450 million, with a majority of this to be returned to shareholders. Admiral expects the deal to close in the first half of 2021. ZPG, which stands for Zoopla Property Group, will control the acquired businesses through its comparison site division, RVU - which operates Confused.com rival Uswitch.

At the other end of the large-cap index, banks were the worst performers amid uncertainty over future implications of the UK's Brexit deal on the financial services sector.

Lloyds Banking was down 3.8%, NatWest down 3.0%, Barclays,down 2.8%, and HSBC down 1.0%.

"First banks were lower because of no trade deal, now banks are lower because of a limited trade deal. There are many positives, but there will be a lot of disruptions in the UK banking circle getting access to the single market, but the problem is no one knows where financial services fit into this deal. Financial services were not a bigger priority in the deal," explained Axi's Stephen Innes. "It leaves a cloud of uncertainty hanging over London financial markets, and investors will have to wait until January to learn what type of access UK banks have to the single market."

Elsewhere in London, THG Holdings was up 5.2%. The Hut Group owner agreed to acquire US-based online skincare and specialty beauty brands retailer Dermstore.com, for USD350 million in cash from major retailer Target Corp, subject to US regulatory approval.

THG said the Dermstore.com acquisition provides the opportunity to accelerate the growth of its own beauty brands via a new and large US customer base.

In addition, THG acquired two of its long-standing UK-based nutrition product suppliers, Claremont Ingredients and David Berryman, for a combined purchase price of GBP59.5 million in cash.

The pound was quoted at USD1.3511 on Tuesday at midday, down from USD1.3587 at the London equities close on Christmas Eve.

The euro was priced at USD1.2250, up from USD1.2197. Against the yen, the dollar was trading at JPY103.63, flat from JPY103.62.

Brent oil was quoted at USD51.55 a barrel Tuesday at midday, sharply higher than USD50.74 at the London equities close Thursday. Gold was priced at USD1,879.35 an ounce, up from USD1,874.60.

"Investors are optimistic about oil prices, and they believe that the pandemic relief aid package along with the coronavirus vaccine should continue to improve oil demand. There is also optimism about the tightening of oil supply, and traders believe that US crude oil stockpiles should continue to see more tightening position," said AvaTrade analyst Naeem Aslam.

Wall Street has more records in its sights, as investors cheered the passage of a much-needed US stimulus bill. This has tempered fears about surging coronavirus infections.

The Dow Jones Industrial Average was called up 0.5%, the S&P 500 up 0.4% and the Nasdaq Composite up 0.5%. All three major indices set record closes on Monday.

US President Donald Trump signed into law the USD900 billion coronavirus relief bill and the USD1.4 trillion federal government budget on Sunday after days of delays. The move offers respite for investors following months of bickering between Democrats and Republicans over the size of the package.

In the latest developments, the US House of Representatives voted to increase Covid-19 relief cheques in the country to USD2,000, meeting Trump's demand for bigger payments and sending the bill to the Republican-controlled Senate, where the outcome is uncertain.

Democrats led passage of the motion, by 275 to 134, their majority favouring additional assistance. They had earlier settled for smaller USD600 payments in a compromise with Republicans over the big year-end relief bill Trump reluctantly signed into law.

The vote divides Republicans who mostly resist more spending, although many House Republicans joined in support, wary of opposing the president's wishes. Senators are set to return to session on Tuesday to consider the measure, with stiff resistance expected.

By Arvind Bhunjun; arvindbhunjun@alliancenews.com

Copyright 2020 Alliance News Limited. All Rights Reserved.

More News
27 Nov 2023 09:20

LONDON BROKER RATINGS: Peel, Numis up Rightmove; Goldman cuts Entain

(Alliance News) - The following London-listed shares received analyst recommendations Monday morning and Friday:

Read more
23 Nov 2023 18:41

IN BRIEF: AstraZeneca Chair Demare buys shares for over GBP200,000

AstraZeneca PLC - Cambridge-based pharmaceutical company - Chair Michel Demare buys 2,000 shares in total on Wednesday and Tuesday. Buys 1,000 shares for GBP101.05 each on Tuesday and 1,000 shares for GBP101.70 each on Thursday, for a total of GBP202,752.

Read more
20 Nov 2023 10:49

AstraZeneca launches new life sciences tech innovation firm Evinova

(Alliance News) - AstraZeneca PLC on Monday launched Evinova, a new health technology business focused on accelerating innovation across the life sciences sector, delivery of clinical trials and better health outcomes.

Read more
17 Nov 2023 15:20

London close: Stocks higher despite weaker retail sales data

(Sharecast News) - London's stock markets finished in a positive state on Friday despite weaker-than-expected UK retail sales figures.

Read more
17 Nov 2023 12:00

LONDON MARKET MIDDAY: Stocks shrug off downbeat UK retail sales

(Alliance News) - Stock prices in London were up at midday on Friday, as a week of favourable data as far as inflation goes gave investors a reason to overlook disappointing UK retail sales figures.

Read more
17 Nov 2023 09:03

LONDON MARKET OPEN: Stocks up despite UK retail sales growth miss

(Alliance News) - Stock prices in London opened higher on Friday, despite weaker-than-expected October retail sales figures for the UK.

Read more
17 Nov 2023 08:31

TOP NEWS: US approves AstraZeneca's Truqap for form of breast cancer

(Alliance News) - AstraZeneca PLC on Friday said that the US Food & Drug Administration approved its drug Truqap in combination with Faslodex to treat patients with an advanced form of breast cancer.

Read more
17 Nov 2023 07:58

LONDON BRIEFING: UK retail sales fall; AstraZeneca gets US approval

(Alliance News) - Stock prices in London are still set to open higher on Friday, despite October retail sales figures for the UK disappointing shortly before the opening bell.

Read more
17 Nov 2023 07:16

AstraZeneca gets US approval for breast cancer treatment

(Sharecast News) - AstraZeneca's 'Truqap', or capivasertib, in combination with 'Faslodex', or fulvestrant, has secured approval from the US Food and Drug Administration (FDA) for specific breast cancer treatments, the company announced on Friday.

Read more
14 Nov 2023 10:51

TOP NEWS: AstraZeneca Imfinzi fails to meet endpoint in cancer trial

(Alliance News) - AstraZeneca PLC on Tuesday said the Pacific-2 phase III trial for Imfinzi as an early treatment lung cancer immunotherapy treatment administered with chemoradiotherapy, did not meet its primary endpoint.

Read more
14 Nov 2023 09:22

AstraZeneca's latest lung cancer trial fails its primary endpoint

(Sharecast News) - AstraZeneca announced on Tuesday that its 'PACIFIC-2' phase three trial for Imfinzi, or durvalumab, concurrently administered with chemoradiotherapy (CRT), did not achieve its primary endpoint of progression-free survival compared to CRT alone.

Read more
13 Nov 2023 09:45

LONDON BROKER RATINGS: Diageo gets price target cuts; JPMorgan ups M&G

(Alliance News) - The following London-listed shares received analyst recommendations Monday morning:

Read more
9 Nov 2023 15:02

London close: Stocks gain as investors await Powell speech

(Sharecast News) - London's stock markets were buoyant at the close of trading on Thursday, influenced by Chinese inflation data, a substantial influx of corporate news, and a speech from the Fed chair later in the global day.

Read more
9 Nov 2023 12:06

LONDON MARKET MIDDAY: FTSE up despite higher for longer US rates fear

(Alliance News) - European equities were on the up on Thursday, despite lingering US interest rate worries and poor China data.

Read more
9 Nov 2023 11:02

Lancashire Holdings declares special dividend after strong year so far

(Alliance News) - Lancashire Holdings Ltd on Thursday said it approved a capital return of up to USD169 million, and it reported rising gross premiums written for the year-to-date.

Read more

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.